Xiao‐Jing Zhang

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Peng Zhang, Lihua Zhu, Jingjing Cai et al. · Circulation Research · 2020 · 1.2K citations · Full text

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

Yunpeng Yang, Song Qu, Jingao Li et al. · The Lancet Oncology · 2021 · 429 citations

Medicine, Clinical Trials, Immune Checkpoint Inhibitor +8

The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy

Xiao‐Jing Zhang, Yan‐Xiao Ji, Peng Zhang et al. · Nature Medicine · 2016 · 387 citations

Chromatin, Cardiac Reprogramming, Cardiac Hypertrophy +9

An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury

Xiao‐Jing Zhang, Xu Cheng, Zhenzhen Yan et al. · Nature Medicine · 2017 · 222 citations

Key Mediator, Oxidative Stress, Inflammation +17

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

Pi‐Xiao Wang, Yan‐Xiao Ji, Xiao‐Jing Zhang et al. · Nature Medicine · 2017 · 215 citations

Inflammation, Autoimmune Disease, Hepatology +15